TPBG
CL icon

Turning Point Benefit Group’s Colgate-Palmolive CL Stock Holding History

Turning Point Benefit Group’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-54
Closed -$4.27K – 228
2025
Q4 		$4.27K Sell
54
-10
-16% -$784 ﹤0.01% 324
2025
Q3 		$5.06K Buy
+64
New +$5.46K ﹤0.01% 238

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Turning Point Benefit Group's CL Position: Q1 2026 in Review

Turning Point Benefit Group sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 54 shares — an estimated $4.27K sold.

Turning Point Benefit Group first reported a position in CL in Q3 2025 and held it in 2 quarters. The position peaked at $5.06K in Q3 2025. 1,959 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Turning Point Benefit Group reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
  • Turning Point Benefit Group sold 54 Colgate-Palmolive shares in Q1 2026, an estimated $4.27K.
  • Turning Point Benefit Group first reported a position in Colgate-Palmolive in Q3 2025 and held it in 2 quarters.
  • Turning Point Benefit Group's Colgate-Palmolive position peaked at $5.06K in Q3 2025.
  • 1,959 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Turning Point Benefit Group's 13F filing for Q1 2026, filed 12 May 2026.